Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2012 (2012), Article ID 728172, 6 pages
http://dx.doi.org/10.1155/2012/728172
Case Report

Systemic Mastocytosis: A Rare Case of Increased Liver Stiffness

1Department of Medicine, Salem Medical Center and Alcohol Research Center, University of Heidelberg, Zeppelinstraße 11-33, 69121 Heidelberg, Germany
2Department of Medicine III, Mannheim Hospital, University of Heidelberg, Wiesbadener Straße 7-11, 68305 Mannheim, Germany
3Institute of Pathology, University of Heidelberg, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany

Received 2 September 2012; Accepted 19 September 2012

Academic Editors: D. Y. Kim, D. Lorenzin, V. Lorenzo-Zúñiga, and C. Miyabayashi

Copyright © 2012 Stefanie Adolf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Sandrin, B. Fourquet, J. M. Hasquenoph et al., “Transient elastography: a new noninvasive method for assessment of hepatic fibrosis,” Ultrasound in Medicine and Biology, vol. 29, no. 12, pp. 1705–1713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Foucher, L. Castéra, P. H. Bernard et al., “Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations,” European Journal of Gastroenterology and Hepatology, vol. 18, no. 4, pp. 411–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Castéra, J. Vergniol, J. Foucher et al., “Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C,” Gastroenterology, vol. 128, no. 2, pp. 343–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Ganne-Carrié, M. Ziol, V. de Ledinghen et al., “Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases,” Hepatology, vol. 44, no. 6, pp. 1511–1517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Friedrich-Rust, M. F. Ong, S. Martens et al., “Performance of transient elastography for the staging of liver fibrosis: a meta-analysis,” Gastroenterology, vol. 134, no. 4, pp. 960–974, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Castera and M. Pinzani, “Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?” Gut, vol. 59, no. 7, pp. 861–866, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Mueller and L. Sandrin, “Liver stiffness: a novel parameter for the diagnosis of liver disease,” Hepatic Medicine, vol. 2, pp. 49–67, 2010. View at Google Scholar
  8. W. Abdi, J. C. Millan, and E. Mezey, “Sampling variability on percutaneous liver biopsy,” Archives of Internal Medicine, vol. 139, no. 6, pp. 667–669, 1979. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Bedossa, D. Dargère, and V. Paradis, “Sampling variability of liver fibrosis in chronic hepatitis C,” Hepatology, vol. 38, no. 6, pp. 1449–1457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. F. Cadranel, P. Rufat, and F. Degos, “Practices of liver biopsy in France: results of a prospective nationwide survey,” Hepatology, vol. 32, no. 3, pp. 477–481, 2000. View at Google Scholar · View at Scopus
  11. B. Maharaj, R. J. Maharaj, W. P. Leary et al., “Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver,” The Lancet, vol. 1, no. 8480, pp. 523–525, 1986. View at Google Scholar · View at Scopus
  12. A. Regev, M. Berho, L. J. Jeffers et al., “Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2614–2618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Millonig, S. Friedrich, S. Adolf et al., “Liver stiffness is directly influenced by central venous pressure,” Journal of Hepatology, vol. 52, no. 2, pp. 206–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Arena, F. Vizzutti, G. Corti et al., “Acute viral hepatitis increases liver stiffness values measured by transient elastography,” Hepatology, vol. 47, no. 2, pp. 380–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Sagir, A. Erhardt, M. Schmitt, and D. Häussinger, “Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage,” Hepatology, vol. 47, no. 2, pp. 592–595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Millonig, F. M. Reimann, S. Friedrich et al., “Extrahepatic cholestasis increases liver stiffness (fibroScan) irrespective of fibrosis,” Hepatology, vol. 48, no. 5, pp. 1718–1723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Mueller, G. Millonig, L. Sarovska et al., “Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis,” World Journal of Gastroenterology, vol. 16, no. 8, pp. 966–972, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Schnittger, T. M. Kohl, T. Haferlach et al., “KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival,” Blood, vol. 107, no. 5, pp. 1791–1799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. R. Johnson, S. Verstovsek, J. L. Jorgensen et al., “Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow,” Modern Pathology, vol. 22, no. 1, pp. 50–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. P. Horny, K. Sotlar, and P. Valent, “Mastocytosis: state of the art,” Pathobiology, vol. 74, no. 2, pp. 121–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Valent, C. Akin, W. R. Sperr et al., “Mastocytosis: pathology, genetics, and current options for therapy,” Leukemia and Lymphoma, vol. 46, no. 1, pp. 35–48, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R. T. Jensen, “Gastrointestinal abnormalities and involvement in systemic mastocytosis,” Hematology/Oncology Clinics of North America, vol. 14, no. 3, pp. 579–623, 2000. View at Google Scholar · View at Scopus
  23. U. Mickys, A. Barakauskiene, C. De Wolf-Peeters, K. Geboes, and G. De Hertogh, “Aggressive systemic mastocytosis complicated by protein-losing enteropathy,” Digestive and Liver Disease, vol. 39, no. 7, pp. 693–697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. P. Shah, F. Y. Lee, R. Luo, Y. Jiang, M. Donker, and C. Akin, “Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis,” Blood, vol. 108, no. 1, pp. 286–291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Weisberg, P. Manley, J. Mestan, S. Cowan-Jacob, A. Ray, and J. D. Griffin, “AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL,” British Journal of Cancer, vol. 94, no. 12, pp. 1765–1769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. M. Stone, D. J. DeAngelo, V. Klimek et al., “Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412,” Blood, vol. 105, no. 1, pp. 54–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Sanz, A. Burnett, F. Lo-Coco, and B. Lowenoerg, “FLT3 inhibition as a targeted therapy for acute myeloid leukemia,” Current Opinion in Oncology, vol. 21, no. 6, pp. 594–600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Cypierre, A. Jaccard, A. Rousseau et al., “Fibroscan is a non-invasive tool for detecting hepatic amyloidosis,” Hepatology, vol. 50, article 921, 2009. View at Google Scholar
  29. A. Lanzi, A. Gianstefani, M. G. Mirarchi, P. Pini, F. Conti, and L. Bolondi, “Liver AL amyloidosis as a possible cause of high liver stiffness values,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 7, pp. 895–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Kohlhaas, E. Durango, G. Millonig et al., “Transient elastography with the XL probe rapidly identifies patients with non-hepatic ascites,” Hepatic Medicine, vol. 4, pp. 11–18, 2012. View at Google Scholar
  31. G. Sebastiani, P. Halfon, L. Castera et al., “SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C,” Hepatology, vol. 49, no. 6, pp. 1821–1827, 2009. View at Publisher · View at Google Scholar · View at Scopus